Biosyent's market cap is currently ―. The company's EPS TTM is C$0.542; its P/E ratio is 15.98; and it has a dividend yield of 1.91%. Biosyent is scheduled to report earnings on May 30, 2024, and the estimated EPS forecast is C$0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	C$ 8.87M	C$ 7.96M	C$ 6.48M	C$ 7.46M	C$ 6.79M
Gross Profit	C$ 7.06M	C$ 6.50M	C$ 5.33M	C$ 6.19M	C$ 5.61M
EBIT	C$ 3.08M	C$ 2.04M	C$ 1.62M	C$ 1.67M	C$ 2.00M
EBITDA	C$ 3.19M	C$ 2.15M	C$ 1.73M	C$ 1.83M	C$ 2.10M
Net Income Common Stockholders	C$ 2.35M	C$ 1.48M	C$ 1.18M	C$ 1.20M	C$ 1.45M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 29.29M	C$ 27.92M	C$ 26.25M	C$ 28.70M	C$ 27.78M
Total Assets	C$ 41.40M	C$ 39.51M	C$ 38.75M	C$ 40.49M	C$ 39.02M
Total Debt	C$ 1.27M	C$ 1.31M	C$ 1.35M	C$ 1.40M	C$ 1.44M
Net Debt	C$ -28.02M	C$ -26.61M	C$ -24.90M	C$ -27.30M	C$ -26.35M
Total Liabilities	C$ 6.85M	C$ 6.44M	C$ 5.33M	C$ 7.12M	C$ 6.02M
Stockholders Equity	C$ 34.55M	C$ 33.07M	C$ 33.42M	C$ 33.36M	C$ 33.00M
Cash Flow	-
Free Cash Flow	C$ 2.39M	C$ 3.06M	C$ -1.19M	C$ 1.87M	C$ 1.20M
Operating Cash Flow	C$ 2.41M	C$ 3.07M	C$ -1.10M	C$ 2.16M	C$ 1.28M
Investing Cash Flow	C$ -976.08K	C$ 1.83M	C$ 949.05K	C$ -1.48M	C$ 1.98M
Financing Cash Flow	C$ -1.14M	C$ -2.03M	C$ -1.33M	C$ -1.01M	C$ -1.41M

Currency in CAD

Biosyent Earnings and Revenue History

Income Statement >

Biosyent Debt to Assets

Balance Sheet >

Biosyent Cash Flow

Cash Flow >

Biosyent Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing